Generation Bio Co reports results for the quarter ended in September - Earnings Summary

Generation Bio

08/11/2022 11:59

* Generation Bio Co  GBIO.OQ  reported a quarterly adjusted
loss
of 53 cents​​ per share for the quarter ended in September. The
mean expectation of seven analysts for the quarter was for a
loss of 67 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Generation Bio Co's reported EPS for the quarter was a
loss
of 53 cents​.
    * The mean earnings estimate of analysts had risen by
about 1.3%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Generation Bio Co shares had risen by 21.8% this
quarter and
lost 8.6% so far this year.
    * The company reported a quarterly loss of $31.31 million.
    * Wall Street's median 12-month price target for Generation
Bio Co
is $17.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
8 at 11:59 a.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -0.67          -0.53          Beat
 Jun. 30 2022      -0.62          -0.66          Missed
 Mar. 31 2022      -0.52          -0.61          Missed
 Dec. 31 2021      -0.57          -0.54          Beat